Seattle’s Infectious Disease Research Institute Announces Amended License Agreement With Merck
SEATTLE, Aug. 3, 2020 /PRNewswire-PRWeb/ -- Seattle's Infectious Disease Research Institute (IDRI) today announced that an agreement has been reached, to...